Review article · 7 Sep 2017
Conference abstract
Re-thinking vaccinology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T o eliminate safety risks related to infectivity, inactivated pathogens and, more suitably, well-characterized pathogen- derived antigens (Ags) have increasingly been used as immunogens in ?modern? vaccines. The selection of these Ags is usually based on their capacity to naturally induce immune responses that ?correlate? with protection.. These Ags, however, are known to be antigenically variable (e.g., conformational Bc epitopes) and/ or subject to immunogenetic restriction (e.g., linear, cell-bound epitopes). In addition, the immunogenicity of ?good? vaccinal Ags is largely dependent on memory CD4 + T helper cells. However, activation of the latter upon natural infection or foreign Ag exposure of genetically predisposed subjects has been associated with immune pathology. Priming of CD4 + T helper cells by adjuvanted vaccines is, therefore, increasingly raising safety concerns. On the other hand, Ags that are highly conserved and of vital importance to the pathogen (hence, called ?protective?) are either not included in contemporary vaccines or not effectively recognized by the host immune system since either deprived of cognate CD4 + T help or outcompeted by other pathogen-derived ?decoy? epitopes for binding to MHC molecules. Hence, we consider that new technologies enabling immune targeting of such protective epitopes by natural, universal (i.e., MHC-nonrestricted) immune helper cells is the new Holy Grail for modern vaccinology.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 24 Dec 2021
Re-Thinking the working capital management and financial performance practices for Bigbend planters group grower firms, Eswatini
Conference abstract · 14 Oct 2019
Re-thinking the relationship between economic performance and suicide in the US: Time series analysis
Conference abstract · 18 Jan 2019
Re-Think recovery
Review article · 8 Oct 2018
What happened to post-imperial development in Africa during the last fifty years? Re-thinking the post-colonial turn in creative art, social â??writingsâ?? and films
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Geert Vanden Bossche”
